APA (7th ed.) Citation

FA, A., AB, K., O, d., S, M., FL, S., V, L., . . . JR, K. (2025). Reutericyclin, a specialized metabolite of Limosilactobacillus reuteri, mitigates risperidone-induced weight gain in mice. Gut microbes, 17(1), 2477819. https://doi.org/10.1080/19490976.2025.2477819

Chicago Style (17th ed.) Citation

FA, Aboulalazm, et al. "Reutericyclin, a Specialized Metabolite of Limosilactobacillus Reuteri, Mitigates Risperidone-induced Weight Gain in Mice." Gut Microbes 17, no. 1 (2025): 2477819. https://doi.org/10.1080/19490976.2025.2477819.

MLA (9th ed.) Citation

FA, Aboulalazm, et al. "Reutericyclin, a Specialized Metabolite of Limosilactobacillus Reuteri, Mitigates Risperidone-induced Weight Gain in Mice." Gut Microbes, vol. 17, no. 1, 2025, p. 2477819, https://doi.org/10.1080/19490976.2025.2477819.